Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party

Measurable residual disease (MRD; previously termed minimal residual disease) is an independent, postdiagnosis, prognostic indicator in acute myeloid leukemia (AML) that is important for risk stratification and treatment planning, in conjunction with other well-established clinical, cytogenetic, and...

Full description

Bibliographic Details
Main Authors:	Schuurhuis, G, Heuser, M, Freeman, S, Béné, M, Buccisano, F, Cloos, J, Grimwade, D, Haferlach, T, Hills, R, Hourigan, C, Jorgensen, J, Kern, W, Lacombe, F, Maurillo, L, Preudhomme, C, Van Der Reijden, B, Thiede, C, Venditti, A, Vyas, P, Wood, B, Walter, R, Döhner, K, Roboz, G, Ossenkoppele, G
Format:	Journal article
Language:	English
Published:	American Society of Hematology 2018

Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party

Similar Items